Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study

Objectives: To assess the demographic and clinical characteristics, treatment and health outcome, and economic burden of juvenile-onset recurrent respiratory papillomatosis (JoRRP) in China. Methods: We identified twelve hospitals mainly responsible for JoRRP management across China to enroll patien...

Full description

Saved in:
Bibliographic Details
Main Authors: Changchang Dun, Yutong Li, Wenbin Lei, Yun Li, Hui Yang, Yalikun Yasen, Nilipaer Alimu, Dapeng Lei, Dongyan Chen, Qingquan Hua, Zhen Xu, Zhe Zhang, Guangke Wang, Weiwei Wang, Li Shi, Xin Wang, Xuelian Zhao, Shangying Hu, Xiaoguang Ni, Jie Zhang, Jun Wang, Fanghui Zhao
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971225001961
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849699284721598464
author Changchang Dun
Yutong Li
Wenbin Lei
Yun Li
Hui Yang
Yalikun Yasen
Nilipaer Alimu
Dapeng Lei
Dongyan Chen
Qingquan Hua
Zhen Xu
Zhe Zhang
Guangke Wang
Weiwei Wang
Li Shi
Xin Wang
Xuelian Zhao
Shangying Hu
Xiaoguang Ni
Jie Zhang
Jun Wang
Fanghui Zhao
author_facet Changchang Dun
Yutong Li
Wenbin Lei
Yun Li
Hui Yang
Yalikun Yasen
Nilipaer Alimu
Dapeng Lei
Dongyan Chen
Qingquan Hua
Zhen Xu
Zhe Zhang
Guangke Wang
Weiwei Wang
Li Shi
Xin Wang
Xuelian Zhao
Shangying Hu
Xiaoguang Ni
Jie Zhang
Jun Wang
Fanghui Zhao
author_sort Changchang Dun
collection DOAJ
description Objectives: To assess the demographic and clinical characteristics, treatment and health outcome, and economic burden of juvenile-onset recurrent respiratory papillomatosis (JoRRP) in China. Methods: We identified twelve hospitals mainly responsible for JoRRP management across China to enroll patients presenting for JoRRP between Jan 1, 2011, and Dec 31, 2021. Data were primarily extracted from medical records, and missing values were additionally collected through telephone or outpatient interviews by two researchers independently. We used counts (proportions) and median values (interquartile range, IQR) to describe data. We applied the Lorenz curve and the concentration index (C-index) to indicate the wealth-related and education-related inequalities in JoRRP. Results: Of the 361 enrolled JoRRP patients, the median age at first diagnosis was 2.7 years (IQR: 1.5-5.0). During the 7.2-year median follow-up, we observed that 314 (87.0%) patients experienced relapse and 125 (38.0%) patients underwent an aggressive clinical course. The median value for the estimated total economic costs per patient was 8717.5$ (IQR: 4700.6$-15359.1$) and the occurrence of catastrophic health expenditure was concentrated in families with low incomes and less-educated parents. Conclusion: Chinese JoRRP patients experienced significant disease burden characterized by severe clinical symptoms and substantial economic costs. Strategic healthcare plans for JoRRP are needed for disease mitigation in China.
format Article
id doaj-art-d7e20bf2db494ff7b86d264fe9d3c282
institution DOAJ
issn 1201-9712
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj-art-d7e20bf2db494ff7b86d264fe9d3c2822025-08-20T03:18:38ZengElsevierInternational Journal of Infectious Diseases1201-97122025-09-0115810797210.1016/j.ijid.2025.107972Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide studyChangchang Dun0Yutong Li1Wenbin Lei2Yun Li3Hui Yang4Yalikun Yasen5Nilipaer Alimu6Dapeng Lei7Dongyan Chen8Qingquan Hua9Zhen Xu10Zhe Zhang11Guangke Wang12Weiwei Wang13Li Shi14Xin Wang15Xuelian Zhao16Shangying Hu17Xiaoguang Ni18Jie Zhang19Jun Wang20Fanghui Zhao21School of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Otorhinolaryngology, Head and Neck Surgery, Hunan Children’s Hospital, Changsha, ChinaDepartment of Otolaryngology-Head & Neck Surgery, West China Hospital of Sichuan University, Chengdu, ChinaDepartment of Otorhinolaryngology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, ChinaDepartment of Otorhinolaryngology, The First Affiliated Hospital of Xinjiang Medical University, Xinjiang, ChinaDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission Key Laboratory of Otorhinolaryngology (Shandong University), Jinan, ChinaDepartment of Otorhinolaryngology, Qilu Hospital of Shandong University, National Health Commission Key Laboratory of Otorhinolaryngology (Shandong University), Jinan, ChinaDepartment of Otolaryngology‐Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Otolaryngology‐Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan, ChinaDepartment of Otolaryngology-Head and Neck Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, ChinaDepartment of Otorhinolaryngology Head and Neck Surgery, Henan Provincial People’s Hospital; Zhengzhou University People’s Hospital, Zhengzhou, ChinaDepartment of Otorhinolaryngology Head and Neck Surgery, Henan Provincial People’s Hospital; Zhengzhou University People’s Hospital, Zhengzhou, ChinaDepartment of Otolaryngology-Head and Neck Surgery, Xijing Hospital, Air Force Medical University, Xi’an, ChinaDepartment of Otolaryngology, The First Hospital, Jilin University, Changchun, ChinaNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, ChinaDepartment of Otolaryngology, Head and Neck Surgery, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, ChinaDepartment of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Key Laboratory of Otolaryngology Head and Neck Surgery (Capital Medical University), Ministry of Education, Beijing, ChinaSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Corresponding author: Fanghui Zhao, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.Objectives: To assess the demographic and clinical characteristics, treatment and health outcome, and economic burden of juvenile-onset recurrent respiratory papillomatosis (JoRRP) in China. Methods: We identified twelve hospitals mainly responsible for JoRRP management across China to enroll patients presenting for JoRRP between Jan 1, 2011, and Dec 31, 2021. Data were primarily extracted from medical records, and missing values were additionally collected through telephone or outpatient interviews by two researchers independently. We used counts (proportions) and median values (interquartile range, IQR) to describe data. We applied the Lorenz curve and the concentration index (C-index) to indicate the wealth-related and education-related inequalities in JoRRP. Results: Of the 361 enrolled JoRRP patients, the median age at first diagnosis was 2.7 years (IQR: 1.5-5.0). During the 7.2-year median follow-up, we observed that 314 (87.0%) patients experienced relapse and 125 (38.0%) patients underwent an aggressive clinical course. The median value for the estimated total economic costs per patient was 8717.5$ (IQR: 4700.6$-15359.1$) and the occurrence of catastrophic health expenditure was concentrated in families with low incomes and less-educated parents. Conclusion: Chinese JoRRP patients experienced significant disease burden characterized by severe clinical symptoms and substantial economic costs. Strategic healthcare plans for JoRRP are needed for disease mitigation in China.http://www.sciencedirect.com/science/article/pii/S1201971225001961Juvenile-onset recurrent respiratory papillomatosisHuman papillomavirusDisease characteristicsEconomic burdenHealth inequality
spellingShingle Changchang Dun
Yutong Li
Wenbin Lei
Yun Li
Hui Yang
Yalikun Yasen
Nilipaer Alimu
Dapeng Lei
Dongyan Chen
Qingquan Hua
Zhen Xu
Zhe Zhang
Guangke Wang
Weiwei Wang
Li Shi
Xin Wang
Xuelian Zhao
Shangying Hu
Xiaoguang Ni
Jie Zhang
Jun Wang
Fanghui Zhao
Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study
International Journal of Infectious Diseases
Juvenile-onset recurrent respiratory papillomatosis
Human papillomavirus
Disease characteristics
Economic burden
Health inequality
title Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study
title_full Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study
title_fullStr Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study
title_full_unstemmed Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study
title_short Characteristics of juvenile-onset recurrent respiratory papillomatosis in China, 2011-2021: A hospital-based nationwide study
title_sort characteristics of juvenile onset recurrent respiratory papillomatosis in china 2011 2021 a hospital based nationwide study
topic Juvenile-onset recurrent respiratory papillomatosis
Human papillomavirus
Disease characteristics
Economic burden
Health inequality
url http://www.sciencedirect.com/science/article/pii/S1201971225001961
work_keys_str_mv AT changchangdun characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT yutongli characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT wenbinlei characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT yunli characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT huiyang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT yalikunyasen characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT nilipaeralimu characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT dapenglei characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT dongyanchen characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT qingquanhua characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT zhenxu characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT zhezhang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT guangkewang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT weiweiwang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT lishi characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT xinwang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT xuelianzhao characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT shangyinghu characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT xiaoguangni characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT jiezhang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT junwang characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy
AT fanghuizhao characteristicsofjuvenileonsetrecurrentrespiratorypapillomatosisinchina20112021ahospitalbasednationwidestudy